NP Life Sciences Health Industry Group Inc.
Income Statement
| Line Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Revenue | — | $164.6K | $102.0K | $35.0K | $15.0K | $43.0K | — |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | — |
| SG&A Expense | — | $165.3K | $120.9K | $100.7K | $146.1K | $151.9K | — |
| Operating Income | — | $-690 | $-18.9K | $-65.7K | $-131.1K | $-108.9K | — |
| Operating Margin | — | -0.4% | -18.5% | -187.7% | -873.9% | -253.2% | — |
| Interest Expense | — | $645 | $1 | — | — | — | — |
| Pretax Income | — | $-1.3K | $-18.9K | $-65.7K | $-131.1K | $-108.8K | — |
| Income Tax Expense | — | $1.6K | — | — | — | — | — |
| Net Income | — | $-2.9K | $-18.9K | $-65.7K | $-131.1K | $-108.8K | — |
| Net Margin | — | -1.8% | -18.5% | -187.7% | -873.8% | -253.1% | — |
| EPS (Basic) | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| EPS (Diluted) | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Shares Outstanding (Basic) | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 66.7K |
| Shares Outstanding (Diluted) | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 66.7K |
| Dividends Per Share | — | — | — | — | — | — | — |